HAP Trading’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $25.7K | Sell |
15,700
-1,800
| -10% | -$367K | ﹤0.01% | 687 |
|
|
2025
Q2 | $195K | Buy |
+17,500
| New | +$3.25M | 0.02% | 336 |
|
|
2025
Q1 | – | Sell |
-11,900
| Closed | -$67.9K | – | 691 |
|
|
2024
Q4 | $67.9K | Buy |
+11,900
| New | +$2.19M | 0.01% | 429 |
|
|
2024
Q1 | – | Sell |
-33,200
| Closed | -$178K | – | 691 |
|
|
2023
Q4 | $178K | Buy |
33,200
+5,000
| +18% | +$729K | 0.03% | 305 |
|
|
2023
Q3 | $325K | Sell |
28,200
-8,800
| -24% | -$1.29M | 0.05% | 249 |
|
|
2023
Q2 | $674K | Sell |
37,000
-3,300
| -8% | -$484K | 0.12% | 156 |
|
|
2023
Q1 | $308K | Sell |
40,300
-4,600
| -10% | -$703K | 0.05% | 246 |
|
|
2022
Q4 | $358K | Sell |
44,900
-8,400
| -16% | -$1.29M | 0.04% | 348 |
|
|
2022
Q3 | $977K | Buy |
53,300
+8,300
| +18% | +$1.19M | 0.07% | 251 |
|
|
2022
Q2 | $616K | Sell |
45,000
-20,600
| -31% | -$3.15M | 0.03% | 388 |
|
|
2022
Q1 | $529K | Sell |
65,600
-10,100
| -13% | -$1.47M | 0.02% | 522 |
|
|
2021
Q4 | $101K | Sell |
75,700
-4,700
| -6% | -$555K | ﹤0.01% | 1229 |
|
|
2021
Q3 | $363K | Buy |
80,400
+32,400
| +68% | +$3.7M | 0.01% | 787 |
|
|
2021
Q2 | $172K | Sell |
48,000
-29,100
| -38% | -$3.28M | 0.01% | 1057 |
|
|
2021
Q1 | $189K | Sell |
77,100
-41,416
| -35% | -$4.43M | 0.01% | 785 |
|
|
2020
Q4 | $88K | Buy |
118,516
+15,600
| +15% | +$1.5M | ﹤0.01% | 1220 |
|
|
2020
Q3 | $345K | Buy |
102,916
+6,636
| +7% | +$625K | 0.02% | 492 |
|
|
2020
Q2 | $292K | Buy |
96,280
+23,880
| +33% | +$2.1M | 0.02% | 581 |
|
|
2020
Q1 | $591K | Sell |
72,400
-28,900
| -29% | -$2.46M | 0.04% | 322 |
|
|
2019
Q4 | $139K | Buy |
101,300
+57,200
| +130% | +$4.75M | 0.01% | 511 |
|
|
2019
Q3 | $166K | Sell |
44,100
-1,500
| -3% | -$103K | 0.01% | 529 |
|
|
2019
Q2 | $196K | Buy |
45,600
+6,900
| +18% | +$542K | 0.02% | 499 |
|
|
2019
Q1 | $151K | Buy |
38,700
+24,300
| +169% | +$1.99M | 0.01% | 486 |
|
|
2018
Q4 | $26K | Buy |
+14,400
| New | +$1.27M | ﹤0.01% | 834 |
|
|
2018
Q3 | – | Sell |
-11,200
| Closed | -$76K | – | 977 |
|
|
2018
Q2 | $76K | Sell |
11,200
-4,400
| -28% | -$430K | ﹤0.01% | 607 |
|
|
2018
Q1 | $169K | Buy |
15,600
+1,800
| +13% | +$198K | 0.01% | 475 |
|
|
2017
Q4 | $4K | Sell |
13,800
-300
| -2% | -$28.3K | ﹤0.01% | 916 |
|
|
2017
Q3 | $21K | Sell |
14,100
-34,900
| -71% | -$2.66M | ﹤0.01% | 746 |
|
|
2017
Q2 | $7K | Buy |
49,000
+7,400
| +18% | +$497K | ﹤0.01% | 865 |
|
|
2017
Q1 | $101K | Buy |
41,600
+20,900
| +101% | +$1.31M | 0.01% | 573 |
|
|
2016
Q4 | $6K | Sell |
20,700
-400
| -2% | -$24.4K | ﹤0.01% | 883 |
|
|
2016
Q3 | $19K | Sell |
21,100
-18,800
| -47% | -$1.22M | ﹤0.01% | 876 |
|
|
2016
Q2 | $58K | Buy |
39,900
+17,500
| +78% | +$1.07M | ﹤0.01% | 588 |
|
|
2016
Q1 | $34K | Sell |
22,400
-164,000
| -88% | -$9.14M | ﹤0.01% | 576 |
|
|
2015
Q4 | $73K | Sell |
186,400
-9,900
| -5% | -$570K | ﹤0.01% | 593 |
|
|
2015
Q3 | $640K | Buy |
196,300
+2,100
| +1% | +$137K | 0.03% | 336 |
|
|
2015
Q2 | $126K | Buy |
194,200
+22,200
| +13% | +$1.45M | 0.01% | 541 |
|
|
2015
Q1 | $452K | Buy |
172,000
+19,100
| +12% | +$1.15M | 0.03% | 352 |
|
|
2014
Q4 | $312K | Buy |
152,900
+38,800
| +34% | +$2.45M | 0.01% | 509 |
|
|
2014
Q3 | $497K | Sell |
114,100
-196,200
| -63% | -$10.9M | 0.02% | 468 |
|
|
2014
Q2 | $186K | Buy |
+310,300
| New | +$16.3M | 0.01% | 579 |
|
|
2014
Q1 | – | Sell |
-136,600
| Closed | -$20K | – | 975 |
|
|
2013
Q4 | $20K | Buy |
136,600
+1,200
| +0.9% | +$59K | ﹤0.01% | 973 |
|
|
2013
Q3 | $264K | Sell |
135,400
-834,600
| -86% | -$37M | 0.01% | 659 |
|
|
2013
Q2 | $1.16M | Buy |
+970,000
| New | +$42.4M | 0.04% | 314 |
|
Other funds holding ABBV
HAP Trading's ABBV Position: Q3 2025 in Review
HAP Trading sold out of AbbVie (ABBV) in Q3 2025, closing a stake of 14,777 shares — an estimated $3.01M sold.
HAP Trading first reported a position in ABBV in Q2 2013 and held it in 24 quarters. The position peaked at $17.2M in Q2 2013. 3,906 funds tracked by Wall St. Rank hold ABBV as of Q3 2025.
- HAP Trading reported no remaining AbbVie position as of Q3 2025 after selling out during the quarter.
- HAP Trading sold 14,777 AbbVie shares in Q3 2025, an estimated $3.01M.
- HAP Trading first reported a position in AbbVie in Q2 2013 and held it in 24 quarters.
- HAP Trading's AbbVie position peaked at $17.2M in Q2 2013.
- 3,906 funds tracked by Wall St. Rank held AbbVie as of Q3 2025.
Based on HAP Trading's 13F filing for Q3 2025, filed 12 Nov 2025.